Funded Data and Analytics Startups in Madrid
In Madrid’s data and analytics funding list, one disclosed round stands out: ONUM’s Series A on 2024-04-10 at $28M, far above the other disclosed amounts i…
In Madrid’s data and analytics funding list, one disclosed round stands out: ONUM’s Series A on 2024-04-10 at $28M, far above the other disclosed amounts in the table (e.g., fintonic at $15M on 2023-06-14 and the $6M–$4M cluster around several 2023 entries). Most disclosed rounds cluster in the same general band rather than spreading evenly: $4M appears repeatedly (Genasys 2026-06-09, Algori 2025-12-09, MedUX 2023-06-07), while earlier disclosed deals run from $1M (Chargy 2022-04-25) up to the $3M–$6M range (Transparent 2021-07-02 at $3M; Atani 2023-10-24 at $6M).
Stage and disclosure labeling skew toward missing detail: 5 of the 10 rows are marked “Series Unknown” (Xcalibur 2026-06-22; Genasys 2026-06-09; Algori 2025-12-09; Atani 2023-10-24; MedUX 2023-06-07), and 2 rows are “undisclosed” (Xcalibur 2026-06-22 and Chargy 2022-04-25). The round dates span 2021-07-02 (Transparent) through 2026-06-22 (Xcalibur), with the newest entry landing in the final days of June 2026.
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed funding amount in this Madrid data-and-analytics set, and how extreme is it versus the rest?
ONUM’s $28M Series A (2024-04-10) is the only disclosed amount at that level in the table; the next-highest disclosed rounds are fintonic’s $15M (2023-06-14) and then $6M (Atani 2023-10-24), with most other disclosed deals at $4M–$3M or below (e.g., Transparent $3M on 2021-07-02).
Do multiple deals concentrate in a narrow time window, or are dates spread evenly across the period shown?
The dates are not evenly distributed: there’s a dense cluster in 2023 (fintonic 2023-06-14 at $15M; MedUX 2023-06-07 at $4M; Atani 2023-10-24 at $6M), plus additional activity in 2022 (Chargy 2022-04-25 at $1M; Wenalyze 2022-03-24 at $2M). The list also extends to 2025–2026 (Algori 2025-12-09 at $4M; Genasys 2026-06-09 at $4M; Xcalibur 2026-06-22 is undisclosed).
Which disclosure patterns dominate here: “Series Unknown” or explicitly disclosed rounds?
Within the 10 rows, 5 are labeled “Series Unknown” (Xcalibur 2026-06-22; Genasys 2026-06-09; Algori 2025-12-09; Atani 2023-10-24; MedUX 2023-06-07), 2 are “undisclosed” (Xcalibur and Chargy 2022-04-25), and only 1 row shows an explicit Series designation besides “Venture - Series Unknown” entries (ONUM as Series A on 2024-04-10).
What stage mix appears most often when you include rows that explicitly say “Venture”?
When the stage label is used, the most common labeled category is “Series Unknown” at 5 of 10 rows (including Genasys 2026-06-09 at $4M and Algori 2025-12-09 at $4M). Separately, two rows use “Venture - Series Unknown” (Wenalyze 2022-03-24 at $2M and Transparent 2021-07-02 at $3M), while ONUM is the single “Series A” example (2024-04-10 at $28M).
Are there any smaller disclosed outliers worth flagging alongside the $28M outlier?
Yes—Chargy’s undisclosed-labeled row is paired with the smallest disclosed amount in the table: $1M on 2022-04-25 (Chargy). That sits below the next-smallest disclosed amounts (Wenalyze at $2M on 2022-03-24 and Transparent at $3M on 2021-07-02), while most other disclosed deals cluster between $4M and $6M (e.g., MedUX $4M on 2023-06-07; Atani $6M on 2023-10-24).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.